Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Dr. Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Endocrine and Metabolism Research Center | Iran

Dr. Fatemeh Shirani is a distinguished scholar in the field of Nutritional Sciences, renowned for her groundbreaking contributions to clinical nutrition, dietary epidemiology, and metabolic health. She has consistently advanced the understanding of how diet and nutrition influence chronic disease prevention and treatment, with a strong emphasis on obesity, diabetes, and cardiovascular disease. Through her innovative research and global collaborations, she has established herself as a thought leader whose work bridges scientific evidence with practical dietary strategies for public health. Currently serving at the Endocrine and Metabolism Research Center of Isfahan University of Medical Sciences, she has become a role model for women in science through her dedication, mentorship, and international engagement.

Professional Profile

Google Scholar

ORCID

Education

Dr. Fatemeh Shirani completed her academic journey with distinction in Nutritional Sciences, earning her foundational and advanced degrees from leading Iranian institutions. She further enriched her expertise through doctoral-level research at Ahvaz Jundishapur University of Medical Sciences, where she focused on the intricate links between nutrition and chronic diseases. Her academic training was complemented by international research at Victoria University in Melbourne, Australia, where she deepened her skills in nutritional biomedicine and clinical research methodologies. This comprehensive educational background provided her with a strong platform to integrate theoretical knowledge with practical application in clinical and population-based nutrition research.

Experience

Dr. Fatemeh Shirani has accumulated extensive experience across research, teaching, and scientific service. She has contributed to large-scale community-based projects, such as national nutrition surveys and heart health programs, aimed at improving public health outcomes through evidence-based interventions. As a dedicated educator, she has taught undergraduate and graduate students, instilling in them the principles of basic nutrition, clinical dietetics, and community health. Her expertise extends to laboratory techniques such as PCR and cell culture, which she has applied to translational nutrition studies. Beyond academia, she has actively participated as a reviewer for prestigious international journals, shaping the quality of published science in her field. Her professional journey reflects a balance of teaching, research, community service, and scientific leadership.

Research Interests

Dr. Fatemeh Shirani’s research interests lie at the intersection of nutrition, epidemiology, and chronic disease management. She is deeply invested in exploring obesity and weight-loss strategies, nutritional interventions for diabetes and metabolic disorders, and the role of diet in preventing cardiovascular disease. Her work also investigates the emerging field of “infectobesity,” examining the connections between viral infections and obesity. By employing systematic reviews, meta-analyses, and clinical trials, she provides high-quality evidence that informs dietary recommendations and policy guidelines. Her studies not only address the biological mechanisms of nutrition-related diseases but also emphasize the translation of findings into practical interventions for populations at risk.

Awards

Dr. Fatemeh Shirani has been widely recognized for her contributions to nutritional sciences, particularly her ability to merge clinical expertise with public health perspectives. Her nomination for the Women Researcher Award reflects her outstanding achievements in advancing women’s representation in scientific leadership and her sustained impact on global nutrition research. She has consistently demonstrated excellence through her publications, conference presentations, and active participation in national and international nutrition societies. This recognition highlights not only her scientific accomplishments but also her commitment to mentoring young researchers and fostering collaborative networks across borders.

Publication

Dr. Fatemeh Shirani has produced a rich body of work that has been widely cited in international literature. Selected publications include:

Title: Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases incidence: a systematic review and meta-analysis
Journal: Nutrition
Published on: 2013
Citation: 482

Title: The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta‐analysis of randomized controlled trials
Journal: Obesity Reviews
Published on: 2016
Citation: 308

Title: Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials
Journal: Nutrition
Published on: 2013
Citation: 288

Title: The role of magnesium in sleep health: a systematic review of available literature
Journal: Biological Trace Element Research
Published on: 2023
Citation: 104

Title: Is phase angle a valuable prognostic tool in cancer patients’ survival? A systematic review and meta-analysis of available literature
Journal: Clinical Nutrition
Published on: 2021
Citation: 98

Title: Vinegar consumption can attenuate postprandial glucose and insulin responses; a systematic review and meta-analysis of clinical trials
Journal: Diabetes Research and Clinical Practice
Published on: 2017
Citation: 95

Title: Effects of concentrated pomegranate juice on subclinical inflammation and cardiometabolic risk factors for type 2 diabetes: A quasi-experimental study
Journal: International Journal of Endocrinology and Metabolism
Published on: 2016
Citation: 55

Conclusion

In conclusion, Dr. Fatemeh Shirani stands as a leading figure in nutritional sciences whose contributions have advanced both research and practice in the prevention and management of chronic diseases. Her ability to translate complex scientific findings into practical dietary strategies has had a lasting impact on public health. With her strong publication record, global collaborations, and dedication to mentorship, she exemplifies the qualities of an outstanding woman researcher. Her nomination for the Women Researcher Award reflects not only her academic excellence but also her leadership, vision, and commitment to improving health outcomes through nutrition science.

Sezgin Gunes | Medicine and Health Sciences | Best Academic Researcher Award

Prof. Sezgin Gunes | Medicine and Health Sciences | Best Academic Researcher Award

Ondokuz Mayis University | Turkey

Prof. Sezgin Gunes is a renowned academic leader and medical researcher whose career has been defined by an unwavering commitment to advancing knowledge in medical biology and reproductive sciences. As Chair of the Department of Medical Biology at the Faculty of Medicine, Ondokuz Mayis University, she has led pioneering research in molecular medicine, andrology, and clinical genetics. Her scholarly journey reflects a distinguished blend of academic leadership, mentorship, and impactful contributions to scientific literature. Through international collaborations, high-impact publications, and mentorship of young researchers, Prof. Sezgin Gunes has established herself as one of the leading voices in reproductive health and molecular biology.

Professional Profile

Scopus

Google Scholar

ORCID

Education

Prof. Sezgin Gunes holds a Bachelor of Science degree in Biological Sciences from Middle East Technical University, followed by a Master of Science and Doctor of Philosophy in Medical Biology from the Faculty of Medicine, Ondokuz Mayis University. Her solid academic foundation in biology and medical sciences enabled her to pursue a successful career as a researcher and educator. She further enhanced her expertise through a competitive research fellowship at the Cleveland Clinic in the United States, where she worked at the American Center of Reproductive Medicine and Andrology. This international training allowed her to engage with global leaders in reproductive health and to develop innovative perspectives on male infertility and molecular diagnostics. Her academic path demonstrates both intellectual depth and a consistent focus on bridging fundamental science with clinical application.

Experience

Prof. Sezgin Gunes has risen through the academic ranks with distinction, serving in multiple leadership and teaching roles at Ondokuz Mayis University. Beginning as a faculty member in Medical Biology, she progressed to leadership roles where she currently chairs the department while also contributing to the Graduate Institute’s Department of Multidisciplinary Molecular Medicine. Beyond her institutional roles, she has played an important part in mentoring both undergraduate and postgraduate students, supervising their research, and guiding them in scientific publishing. Her international engagements include mentoring summer internship programs at the Cleveland Clinic, where she inspired young researchers in reproductive medicine. She has also been actively involved in scientific project management, European Union projects, and advanced training in assisted reproductive techniques. Her career represents a combination of research excellence, administrative leadership, and dedication to academic mentorship.

Research Interests

The research contributions of Prof. Sezgin Gunes are focused on andrology, male infertility, and the molecular mechanisms underlying reproductive health. Her investigations explore sperm DNA fragmentation, chromatin quality, oxidative stress, gene expression, and cytogenetic alterations that contribute to male infertility. In addition, her work on epigenetics and urological malignancies has advanced understanding of how environmental, genetic, and molecular factors interact in reproductive dysfunctions and cancer development. She has explored the role of microRNAs, promoter methylation, and polymorphisms in idiopathic infertility, contributing critical insights into personalized medicine approaches. Her research is not only groundbreaking in the academic sense but also has important translational applications, influencing diagnostic tools and therapeutic strategies in clinical practice.

Awards and Recognition

Throughout her career, Prof. Sezgin Gunes has been recognized with numerous distinctions, fellowships, and certifications that reflect her dedication to advancing science and education. She has been honored with opportunities to conduct research at leading international institutions, gaining exposure to cutting-edge reproductive medicine technologies. Her professional development includes certifications in scientific project management, European Union project management, and advanced training in assisted reproduction. These achievements highlight her versatility as both a scientist and a leader. Her recognition is not limited to academic achievements but also extends to her role as a mentor, project leader, and collaborator in international research networks.

Publications

Prof. Sezgin Gunes has authored an impressive portfolio of publications in leading international journals, making significant contributions to reproductive medicine, molecular biology, and clinical genetics. Her widely cited works include:

  • Smoking and male infertility: an evidence-based review
    Journal: The World Journal of Men’s Health
    Published on: 2015
    Citation: 379

  • Effects of aging on the male reproductive system
    Journal: Journal of Assisted Reproduction and Genetics
    Published on: 2016
    Citation: 320

  • Spermatogenesis, DNA damage and DNA repair mechanisms in male infertility
    Journal: Reproductive Biomedicine Online
    Published on: 2015
    Citation: 275

  • The role of epigenetics in idiopathic male infertility
    Journal: Journal of Assisted Reproduction and Genetics
    Published on: 2016
    Citation: 167

  • Role of genetics and epigenetics in male infertility
    Journal: Andrologia
    Published on: 2021
    Citation: 159

  • Association of interleukin‐10 gene polymorphisms with severe generalized chronic periodontitis
    Journal: Journal of Periodontology
    Published on: 2007
    Citation: 104

  • Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility
    Journal: Rheumatology International
    Published on: 2008
    Citation: 100

Conclusion

Prof. Sezgin Gunes stands out as a visionary researcher, accomplished academic, and respected leader in medical biology and reproductive medicine. Her contributions to the understanding of male infertility, gene expression, cytogenetics, and epigenetics have had profound impact in both research and clinical contexts. With an outstanding record of scientific publications, international collaboration, and mentorship of future scientists, she represents the model of a globally engaged and impactful researcher. Her achievements and leadership make her an ideal candidate for the Best Academic Researcher Award, reflecting her dedication to advancing science and improving human health through innovative and meaningful research.

Shoukui Hu | Medicine and Health Sciences | Best Researcher Award

Dr. Shoukui Hu | Medicine and Health Sciences | Best Researcher Award

Zhengzhou Central Hospital Affiliated to Zhengzhou University | China

Dr. Shoukui Hu is a distinguished medical microbiologist and molecular biologist currently serving as the Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital. With over two decades of impactful work in pathogenic biology, Dr. Hu has been instrumental in advancing public health diagnostics and molecular epidemiology in China. His leadership and research contributions have strengthened clinical laboratory practices and disease surveillance.

Author Profile👤

ORCID

Scopus

Strengths for the Awards✨

Dr. Shoukui Hu brings over two decades of experience in pathogenic biology and molecular biology, having contributed significantly to public health and clinical research in China. He currently serves as the Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital, a role that highlights both his leadership capabilities and clinical expertise. His academic journey, culminating in a Ph.D. from the China CDC, laid a solid foundation for impactful research in infectious diseases, microbiology, and translational diagnostics.

A standout strength is his strong publication record, with at least nine peer-reviewed SCI-indexed articles published in the past five years alone—many as corresponding or first author. These papers cover emerging infectious pathogens such as Candida auris, Helicobacter pylori, Neisseria meningitidis, and Streptococcus pneumoniae, which are critical topics in global public health. His research has been published in high-impact Q1 and Q2 journals such as Gut Microbes, Helicobacter, BMC Genomics, and World Journal of Gastroenterology, demonstrating relevance, innovation, and scientific rigor.

Furthermore, Dr. Hu’s expertise in molecular diagnostics, particularly the development of biosensors and amplification techniques, shows clear translational value, directly impacting clinical diagnostics and public health surveillance systems. His dual expertise in research and hospital management positions him as a bridge between science and clinical application—an invaluable trait for advancing healthcare innovations.

🎓 Education

Dr. Hu began his academic journey with a BSc from Anhui Science and Technology University (1995–1999), followed by an MSc in Microbiology (2001–2004) jointly awarded by the National Institute for Communicable Disease Control and Prevention and Anhui Agricultural University. He then earned his Ph.D. in Pathogeny Biology (2009–2014) from the same institute under the China CDC, equipping him with a deep scientific foundation to drive impactful research.

🧪 Experience

Currently the Senior Technologist and Director at Peking University Shougang Hospital (since 2016), Dr. Hu has also held vital roles such as Postdoctoral Fellow in Molecular Epidemiology at the China CDC (2014–2016) and Associate Senior Technologist at Peking University International Hospital (2014). From 2004 to 2014, he served as Deputy Department Director of the Microbiology Lab at Anhui CDC, where he led several high-level surveillance and diagnostic programs across China.

🔬 Research Interests On Medicine and Health Sciences

Dr. Hu’s research passion lies at the intersection of pathogenic biology and molecular biology. He is particularly focused on Helicobacter pylori infections, gut microbiota, antimicrobial resistance, and the genomic characterization of emerging pathogens. His studies contribute valuable insight into immune mechanisms, pathogen identification, and microbiome-related diseases.

🏆 Awards

While specific awards are not listed in the provided CV, Dr. Hu’s consistent corresponding authorship and leadership in high-impact international publications indicate significant professional recognition. His role in directing laboratory operations at a top-tier hospital and publishing in top Q1 journals further reflects his prestige and contributions to global health science.

📚 Publications

Below are key publications from the past 5 years, with hyperlinks, journal names, years, and citation roles:

  1. Isolation of Fluconazole-Resistant South Asian Clade Candida auris in Beijing, China, American Journal of Tropical Medicine and Hygiene, 2025 – Corresponding Author

  2. Influence of Helicobacter pylori on composition and function of gastric microbiota in patients with chronic non-atrophic gastritis, Heliyon, 2024 – Corresponding Author

  3. The role of toll-like receptors in immune tolerance induced by Helicobacter pylori infection, Helicobacter, 2023 – Corresponding Author

  4. Comparative analysis of the gut microbiota of wild adult rats from nine district areas in Hainan, China, World Journal of Gastroenterology, 2023 – Corresponding Author

  5. Ultra-efficient multiple cross displacement amplification-lateral flow biosensor for serogroup identification of prevalent Neisseria meningitidis, Analytical Biochemistry, 2022 – Corresponding Author

  6. Simultaneous detection of Streptococcus pneumoniae… using multiple cross displacement amplification, FEMS Microbiology Letters, 2021 – Corresponding Author

  7. Hemolysin BL from Bacillus toyonensis BV-17 induces antitumor activity both in vitro and in vivo, Gut Microbes, 2020 – Co-First Author

  8. Genomic analysis of Helicobacter himalayensis sp. nov. isolated from Marmota himalayana, BMC Genomics, 2020 – First Author

  9. Alteration of gut microbiota in type 2 diabetes complicated with cholelithiasis patients, Chinese Medical Journal, 2022 – Corresponding Author

✅ Conclusion

🎖️ Dr. Shoukui Hu is a pioneering clinical researcher and laboratory expert whose work spans epidemiological surveillance, diagnostic innovation, and microbiome science. With a sustained record of leadership, publication, and mentorship, he exemplifies the qualities of a Best Researcher Award nominee. His scholarly output and translational impact make him a key contributor to advancing infectious disease control and laboratory science in China and beyond.

Marwa Refaie | Medicine and Health Sciences | Pioneer Researcher Award

Assist. Prof. Dr. Marwa Refaie | Medicine and Health Sciences | Pioneer Researcher Award

Minya University | Egypt

Dr. Marwa Monier Mahmoud Refaie is an esteemed Egyptian pharmacologist and academician currently serving as an Assistant Professor in the Department of Pharmacology, Faculty of Medicine, Minia University. With an H-index of 18 on both Scopus and Google Scholar, she has made impactful contributions to pharmacological research, particularly in drug safety, toxicology, and disease treatment models. Born on July 2, 1983, in Mallawi, El-Minia, Dr. Refaie balances her thriving career with family life, being a proud mother of three sons.

Professional profile👤

Google Scholar

Scopus

ORCID

Strengths for the Awards✨

Dr. Marwa Monier Mahmoud Refaie demonstrates a remarkable profile that aligns seamlessly with the ethos of the Pioneer Researcher Award. With over 16 years of academic and research experience in pharmacology, she has established herself as a thought leader in experimental and clinical pharmacology, especially in toxicology, nephroprotection, cardioprotection, and hormonal therapy research.

Her impressive H-index of 18 (Scopus & Google Scholar) reflects the consistent impact of her work on the scientific community. Dr. Refaie has authored over 40 international publications, many in high-impact journals, and has investigated novel therapeutic mechanisms for critical conditions like nephrotoxicity, PCOS, and ischemia-reperfusion injuries. Her robust experimental skill set, prolific mentorship of postgraduate students, and service on editorial boards of globally recognized journals (e.g., British Journal of Pharmacology, Elsevier journals) reflect both leadership and innovation in her field. Moreover, her multiple awards from Minia University for international publication over consecutive years affirm her consistency and excellence in pioneering pharmacological research.

🎓 Education

Dr. Refaie began her academic journey at Minia University, earning her MBBS in Medicine and Surgery in 2006. She further specialized in pharmacology, completing her Master’s in 2011 and a Ph.D. in Basic and Clinical Pharmacology in 2016. Expanding her interdisciplinary expertise, she also earned a Diploma in Infection Control in 2021, highlighting her dedication to integrated healthcare education and safety.

🧪 Experience

With over 16 years of academic and research experience, Dr. Refaie has evolved from a Demonstrator to Assistant Professor at Minia University. Her work spans teaching basic and clinical pharmacology to medical, dental, pharmacy, and nursing students, and supervising numerous M.Sc. and Ph.D. theses. Her research explores pharmacotherapy, cancer, autoimmune diseases, and drug safety, and she has actively contributed to institutional accreditation, infection control, and community healthcare education.

🔬 Research Interests On Medicine and Health Sciences

Dr. Refaie’s research is driven by a passion for understanding and combating toxicological and precancerous conditions. Her focus lies in modeling and treating organ-specific toxicity, ischemia-reperfusion injuries, and hyperplastic lesions. Her work also explores novel mechanisms of cardioprotection, reproductive toxicity, and immunomodulation using pharmacological agents such as diacerein, fenofibrate, and SGLT2 inhibitors.

🏆 Awards

Dr. Refaie has received consistent recognition for her excellence in research and publication. She was awarded first place at the 57th Annual Conference of the Egyptian Society of Pharmacology and Experimental Therapeutics (2018). Additionally, she has received Minia University’s International Publication Award for six consecutive years (2019–2024), reflecting her sustained contributions to global pharmacological science.

📚 Publications

  • Effect of coenzyme‐Q10 on doxorubicin‐induced nephrotoxicity in rats
    AAK El-Sheikh, MA Morsy, MM Mahmoud, RA Rifaai, AM Abdelrahman
    2012 – Cited by: 147

  • Possible protective effect of diacerein on doxorubicin‐induced nephrotoxicity in rats
    MMM Refaie, EF Amin, NF El-Tahawy, AM Abdelrahman
    2016 – Cited by: 96

  • Mechanism mediating the protective effect of diacerein in ischemia-reperfusion-induced testicular injury in rats
    SA Abdel-Gaber, RK Mohammed, MMM Refaie
    2018 – Cited by: 62

  • Protective mechanisms of coenzyme-Q10 may involve up-regulation of testicular P-glycoprotein in doxorubicin-induced toxicity
    AAK El-Sheikh, MA Morsy, MM Mahmoud, RA Rifaai
    2014 – Cited by: 52

  • Naringenin palliates cisplatin and doxorubicin gonadal toxicity in male rats
    AA Fouad, MMM Refaie, MI Abdelghany
    2019 – Cited by: 50

  • The role of interleukin‐1β and its antagonist (diacerein) in estradiol benzoate‐induced endometrial hyperplasia and atypia in female rats
    MMM Refaie, M El‐Hussieny
    2017 – Cited by: 48

  • Role of ATP-Sensitive Potassium Channel (KATP) and eNOS in Mediating the Protective Effect of Nicorandil in Cyclophosphamide-Induced Cardiotoxicity
    MMM Refaie, S Shehata, M El-Hussieny, WM Abdelraheem, …
    2020 – Cited by: 46

  • Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
    WM Abdelraheem, MMM Refaie, RKM Yousef, AS Abd El Fatah, …
    2022 – Cited by: 44

  • Protective role of nebivolol in cadmium-induced hepatotoxicity via downregulation of oxidative stress, apoptosis and inflammatory pathways
    MMM Refaie, M El-Hussieny, NM Zenhom
    2018 – Cited by: 43

  • Protective effect of pioglitazone on ovarian ischemia reperfusion injury of female rats via modulation of peroxisome proliferator activated receptor gamma and heme-oxygenase 1
    MMM Refaie, M El-Hussieny
    2018 – Cited by: 41

📝 Conclusion

🌟 Dr. Marwa M. Refaie exemplifies excellence in academic pharmacology through her sustained research, impactful publications, and commitment to medical education. Her work spans cutting-edge experimental pharmacology, disease modeling, and immunotherapy. Her consistent accolades, active international collaborations, and editorial contributions to top journals affirm her candidacy as a distinguished nominee for prestigious research awards. Her legacy in pharmacological sciences continues to inspire and uplift the global scientific community.

 

Hasan Hallaçeli | Medicine | Best Researcher Award

Prof. Dr. Hasan Hallaçeli | Medicine | Best Researcher Award

Hatay Mustafa Kemal University | Turkey

Prof. Dr. Hasan Hallaçeli is a distinguished Turkish physiotherapist and academician specializing in orthopedic rehabilitation. A 1989 graduate of Hacettepe University with a Ph.D. earned in 1996, he is currently serving at Hatay Mustafa Kemal University, Faculty of Medicine. With a visionary approach, he has pioneered the establishment of orthopedic physiotherapy departments in four university hospitals across Turkey. As an honorary member of the Turkish Orthopaedics and Traumatology Association, he has devoted his career to enhancing postoperative rehabilitation, especially for knee, shoulder, and elbow surgeries. Passionate about education and service, he has supervised 10 master’s theses and contributed to over 100 scientific outputs, while actively volunteering in combat sports and for children with disabilities.

Professional profile👤

Google Scholar

Scopus

Strengths for the Awards✨

  • Extensive Academic Background: Ph.D. in Physiotherapy (1996); graduated from Hacettepe University, a top institution in Turkey.

  • Institution Building: Established orthopaedic physiotherapy departments in four university hospitals across Turkey.

  • Research Contributions:

    • Over 100 scientific publications including:

      • 11 SCI-indexed journal articles

      • 19 international/national refereed journal papers

      • 19 book chapters

      • 55 conference presentations

  • Editorial Roles: Editor of three specialized books in orthopaedic physiotherapy.

  • Book Publications:

    • Ortopedik Fizyoterapi ve Rehabilitasyon (2021)

    • Ortopedik Fizyoterapi – Diz (2020)

    • Physiotherapy And Rehabilitation in Knee Joint Extensor Mechanism (2022)

🎓 Education

Dr. Hallaçeli graduated from Hacettepe University’s Faculty of Physiotherapy and Rehabilitation in 1989. He pursued his academic aspirations further and obtained a Ph.D. in 1996. His academic journey reflects a strong foundation in clinical expertise and theoretical rigor, setting the stage for his future innovations in orthopedic physiotherapy.

💼 Experience

Prof. Hallaçeli has held influential academic positions across Turkey, playing a key role in the foundation of orthopedic physiotherapy units in multiple universities. With vast clinical experience, he focuses on rehabilitation following orthopedic surgeries, especially in high-impact joints. His clinical skills, combined with over three decades of academic leadership, have significantly shaped the field in both practice and policy.

🔬 Research Interests On Medicine

His research interests center on orthopedic physiotherapy—particularly the rehabilitation of the shoulder, elbow, and knee—and extend into sports injuries in combat sports. Dr. Hallaçeli also conducts multidisciplinary studies on postural balance and fall risk among patients with knee osteoarthritis and post-prosthetic surgery. His work aims to improve patient safety and athletic performance through scientific insights.

🏆 Awards

Prof. Hallaçeli is recognized as an Honorary Member of the Turkish Orthopaedics and Traumatology Association for his notable contributions to the field. In addition to academic leadership, his dedication to community services—especially for disabled children and combat sports athletes—has further solidified his reputation as a compassionate and impactful professional.

📚 Publications

  • The effect of combined therapy (spa and physical therapy) on pain in various chronic diseases
    A Cimbiz, V Bayazit, H Hallaceli, U Cavlak
    📅 2005 | 📑 73 citations

  • Normal hip, knee and ankle range of motion in the Turkish population
    H Hallaceli, V Uruç, HH Uysal, R Özden, Ç Hallaçeli, F Soyuer, T Parpucu, …
    📅 2014 | 📑 72 citations

  • Importance of anatomy education in physical therapy and rehabilitation in Turkey: A qualitative study
    F Duman, I Huzmeli, B Yucekaya, H Hallaceli, M Gunes
    📅 2017 | 📑 18 citations

  • Normal range of scapular elevation and depression in healthy subjects
    H Hallaceli, I Günal
    📅 2002 | 📑 13 citations

  • A new anchor augmentation technique with a cancellous screw in osteoporotic rotator cuff repair: an in vitro biomechanical study on sheep humerus specimens
    V Uruc, R Ozden, Y Dogramacı, A Kalacı, H Hallaceli, F Küçükdurmaz
    📅 2014 | 📑 12 citations

  • Goniometric Measurements of the Angular Values of the Joints in the Fore-and Hindlimbs of Kangal Dogs
    S Ates, C Hallaceli, H Hallaceli, I Kürtül
    📅 2011 | 📑 11 citations

  • Does scapular elevation accompany glenohumeral abduction in healthy subjects?
    H Hallaceli, M Manisali, I Gunal
    📅 2004 | 📑 11 citations

  • Türk toplumunda kalça diz ve ayak bileğinin normal eklem hareket açıklığı
    H Hallaçeli, V Uruç, HH Uysal, R Özden, Ç Hallaçeli, F Soyuer, …
    📅 2014 | 📑 10 citations

  • Injuries in wheelchair basketball players
    ED Huzmeli, N Katayifci, H Hallaceli
    📅 2017 | 📑 8 citations

  • A new clinical design measuring the vertical axial rotation through tibial shaft resulting from passive knee and subtalar joints rotation in healthy subjects: A reliability study
    A Cımbız, U Cavlak, M Sarı, H Hallaceli, F Beydemir
    📅 2006 | 📑 8 citations

🔚 Conclusion

In conclusion, Prof. Dr. Hasan Hallaçeli’s career embodies excellence in orthopedic physiotherapy, scholarly publishing, and community engagement. With over three decades of dedicated academic, clinical, and volunteer service, he continues to inspire through innovation and empathy. His interdisciplinary focus—bridging rehabilitation, sports, and education—makes him a deserving candidate for any prestigious recognition.

Rui Guo | Medicine | Excellence in Innovation Award

Dr. Rui Guo | Medicine | Excellence in Innovation Award

Children’s Hospital Affiliated to Shandong University | China

Dr. Rui Guo is a thoracic and tumor surgeon specializing in pediatric minimally invasive surgery. Affiliated with the Children’s Hospital of Shandong University and Jinan Children’s Hospital, his work focuses on innovative thoracoscopic techniques for congenital lung malformations.

Professional profile👤

Scopus

Strengths for the Awards✨

  1. Innovative Surgical Technique

    • Introduces a novel “Single Surgeon + Single Site” thoracoscopic approach for pediatric extralobar pulmonary sequestration (ELS), reducing incisions, operative time, and resource use compared to multi-portal VATS (M-VATS).

    • Addresses limitations of existing techniques (e.g., U-VATS) by enabling artificial pneumothorax and minimizing instrument interference.

  2. Clinical Impact

    • Demonstrates superior outcomes: Shorter operative time (41.8 vs. 53.7 min), reduced blood loss (2.7 vs. 4.1 mL), and shorter hospital stays (3.7 vs. 6.5 days) compared to M-VATS.

    • Cost-effective: Lower expenses ($4,228 vs. $4,978) due to fewer consumables and no need for surgical assistants.

  3. Technical Feasibility

    • Successful implementation in 18 patients with no conversions to open surgery or major complications (e.g., bronchopleural fistulas).

    • Adaptability to complex cases (e.g., intra-diaphragmatic ELS with diaphragmatic repair).

  4. Alignment with Modern Surgical Trends

    • Promotes minimally invasive and enhanced recovery protocols, aligning with global shifts toward less traumatic pediatric surgeries.

  5. Rigor and Transparency

    • Retrospective design but includes clear statistical analysis and comparative data.

    • Ethical approval and informed consent were obtained.

Education 🎓

  • Medical Degree: Likely from a Chinese medical institution (specific details not provided in the publication).

  • Training: Specialization in pediatric thoracic surgery, with expertise in video-assisted thoracoscopic surgery (VATS).

Experience 💼

  • Current Roles:

    • Thoracic Surgeon at Jinan Children’s Hospital.

    • Researcher in minimally invasive pediatric surgical techniques.

  • Key Contributions: Pioneered “Single Surgeon” and “Single Site” thoracoscopic approaches for pulmonary sequestration.

Research Interest On Medicine🔍

  • Minimally invasive surgery (VATS) for congenital lung lesions.

  • Cost-effective and resource-efficient surgical techniques.

  • Postoperative recovery optimization in pediatric patients.

Publication 📄

Guo et al. (2025) “Single surgeon and single site total thoracoscopic surgery for paediatric extralobar pulmonary sequestration.” BMC Pediatrics, 25:446.
🔗 Read Here | Cited by: [X] articles (check citation count on PubMed/Google Scholar).

Conclusion ✨

Dr. Rui Guo, innovative thoracoscopic techniques demonstrate improved surgical outcomes, reduced costs, and faster recovery for pediatric ELS patients. His work supports broader adoption of minimally invasive approaches in pediatric thoracic surgery.